臺灣博碩士論文加值系統

Objectives. To investigate the correlations between the elevated urinary β2-MG and the risk of development of neonatal complications.
Methods. Seventy-five very low birth weight (<1500 g) premature infants were enrolled. Urinary β2-MG was measured with immunometric assay within 48 hours and at 28 days of age. Simultaneous urinary creatinine (Cr) was measured and used for the normalization of β2-MG excretion.
Results. The mortality rate was 8% (6/75). Multivariate logistic regression analysis showed that there were positive association of elevated urinary β2-MG with periventricular leukomalacia (PVL) (OR 1.25, 95% CI 1.02-1.63 for 48 hrs; OR 1.18, 95% CI 1.09-1.42 for 28 days ), necrotizing enterocolitis (NEC) (OR 1.12, 95% CI 1.02-1.24 for 48 hrs; OR 1.32, 95% CI 1.06-1.84 for 28 days ), and chronic lung disease (CLD) (OR 1.92, 95% CI 1.24-2.13 for 48 hrs; OR 1.61, 95% CI 1.39-1.94 for 28 days ). No similar association was found in respiratory distress syndrome, symptomatic PDA, pulmonary hemorrhage, intraventricular hemorrhage, sepsis or retinopathy of prematurity.
Conclusions. Urinary β2-MG was significantly higher at early life and sustained higher thereafter at least until 28 days of age in premature infants who developed PVL, NEC or CLD than in those who did not.

中文摘要 p.2
英文摘要 p.3
誌謝辭 p.5
第一章 前言 研究背景及目的 p.6
第二章 研究方法 研究材料、設計與統計方法 p.9
第三章 研究結果 描述性統計分析與推論性統計分析 p.12
第四章 討論 結果討論、其他相關性討論與研究限制 p.15
第五章 結論 p.20
表格 p.21
參考文獻 p.26

REFERENCES
1. Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:192-202.
2. Romero R, Gomez R, Ghezzi F, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186-93.
3. Fung G, Bawden K, Chow P, et al. Chorioamnionitis and outcome in extremely preterm infants. Ann Acad Med Singapore 2003; 32: 305-10.
4. The ACCP/SCCM consensus conference committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-55.
5. Schiller JH, Storer B, Witt, et al. Biological and clinical effects of the combination of β- and α-interferons administered as a 5-day continuous infusion. Cancer Res 1990; 50:4588-94.
6. Assahi FK, John EG, Justice P, et al Beta2-microglobulin clearance in neonate: Index of tubular maturation. Kidney Int 1985; 28: 153-7.
7. Ciardelli V, Rizzo N, Farina A, et al. Prenatal evaluation of fetal renal function based on serum beta (2)-microglobulin assessment. Prenat Diagn 2001; 21: 586-8.
8. Gibbs RS, Blanco JD, St Clair PJ. Quantitative bacteriology of amniotic fluid from patients with clinical intraamniotic infection at term. J Infect Dis 1982;145:1-8.
9. Goldenberg RL, Hauth JC, Andrew WW. Intrauterine infection and preterm delivery. New Engl J Med 2000; 342: 1500-7.
10. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1998; 31:553-84.
11. Leviton A. Preterm birth and cerebral palsy: Is tumor necrosis factor the missing link? Dev Med Child Neurol 1993;35:553-8.
12. Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-α, interleukin-1β, interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997; 177: 825-30.
13. Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19-26.
14. Yoon BH, Romero R, Kim CJ, et al. High expression of tumor necrosis factor –alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 1997; 177: 406-11.
15. Yoon BH. Intrauterine infection and the development of cerebral palsy. BJOG 2003; 110 Suppl 20: 124-7.
16. Svigos JM. The fetal inflammatory response syndrome and cerebral palsy: yet another
challenge and dilemma for the obstetrician. Aust N Z J Obstet Gynaecol 2001; 41:170-6
17. Saliba E: Inflammatory mediators and neonatal brain damage. Biol Neonate 2001; 79: 224-7.
18. Hibi S, Ikushima S, Fujiwara F, et al. Serum and urine beta;2-microglobulin in hemophagocytic syndrome. Cancer 1995;75:1700-5.
19. Su BH, Hu PS, Peng CT, et al. Chronic lung disease in extremely low birth weight infants. Acta Paediatr Tw 2000; 41:75-9.
20. Lee CY, Su BH, Hu PS, et al. Respiratory outcome in extremely low birth weight infants with preterm premature rupture of membrane. Clinical Neonatology 2000;7;17-22.
21. Gersony WM, Peckham GJ, Ellison RC. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983;102:895-906.
22. Couser RJ, Ferrara TB, Wright GB, et al. Prophylactic indomethacin therapy in the first 24 hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room. J Pediatr 1996; 128:631-7.
23. Su BH, Watanabe T, Shimitzu M, et al. Echocardiographic assessment of ductus arteriosus shunt flow pattern in premature infants. Arch Dis Child 1997;77:F36-F40.
24. Grafe M. The correlation of prenatal brain damage with placental pathology. J Neuropathol Exp Neurol 1994;53:407-15.
25. Mittendorf R, Montag AG, MacMillan W, et al. Components of the systemic fetal inflammatory response syndrome as predictors of impaired neurologic outcomes in children. Am J Obstet Gynecol 2003; 188:1438-46.
26. Mittendorf R, Dambrosia J, Pryde PG, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002;186:1111-8.
27. Lin TW, Su BH, Lin HC, et al. Risk factors of pulmonary hemorrhage in very low birth weight infants. Acta Paediatr Tw 2000;41:255-8.
28. Goepfert AR; Andrews WW; Carlo W, et al. Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity. Am J Obstet Gynecol 2004; 191:1375-81.
29. Nishimaki S, Shima Y, Sato M, et al. Urinary beta2-microglobulin in premature infants with chorioamnionitis and chronic lung disease. J Pediatr 2003; 143:120-2.
30. Su BH, Chiu HY, Lin TW, et al. Interleukin-8 in Bronchoalveolar Lavage Fluid from Premature Infants at Risk of Chronic Lung Disease. J Formos Med Ass 2005; 104: 244-8.
31.Tack ED, Perlman JM, Robson AM. Renal injury in sick newborn infants: a prospective evaluation using urinary beta2-microglobulin concentrations. Pediatrics 1988;81:432-40
32. Toth-Heyn P, Drukker A, Guignard JP. The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol 2000;14:227-39
33.Engle WD, Arant BS Jr. Renal handling of beta2-microglobulin in the human neonate. Kidney Int 1983;24:358-63
34.Christian P. Speer. New insights into the pathogenesis of pulmonary inflammation in preterm infants. Biol Neonated 2001;78:205-209